Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Anuncia Relocates-Establishes Scottsdale, Arizona, Operations

07/26/2021
Anuncia Inc., a therapeutic medical device company and emerging leader in cerebrospinal fluid management innovation, is moving its headquarters to Scottsdale, Arizona.

According to company officials, the move to the SkySong, the Arizona State University Scottsdale Innovation Center, is the first geographic expansion for the high growth medtech startup previously based in Massachusetts.

"As we grow and scale manufacturing, our need to expand operations into the Southwest has been met with impressive support from the thriving Greater Phoenix biomedical community, which is anchored by numerous medical centers of excellence including the Barrow Neurological Institute, the Mayo Clinic, and Phoenix Children's Hospital and various major universities,” Elsa Chi Abruzzo, Anuncia's CEO said.

Anuncia is the developer of the US FDA cleared and EU CE Marked commercial ReFlow Ventricular System designed to noninvasively unblock occluded ventriculoperitoneal shunts.

"With a growing and robust healthcare, medtech and wearable ecosystem, Greater Phoenix has become a hub for advanced innovation that supports entrepreneurs in the development of lifesaving technology," said Chris Camacho, President & CEO of the Greater Phoenix Economic Council. "We're excited for Anuncia's entry into the market and look forward to being a partner in their continued growth and success."

Company officials explained as many as half of all intracranial VP shunts fail in the first two years, mainly due to blockages that impair CSF flow. Failures often require emergency revision brain surgery, each costing upwards of $40,000. Early clinical evidence with up to 3-year follow-up indicates Anuncia's planned next generation ReFlow System Mini may uniquely prevent VP shunt malfunctions due to occlusions, at home or in the clinic, to improve clinical outcomes and quality of life, while reducing healthcare costs.

"Anuncia's move to SkySong is demonstrative of the ways in which ASU's efforts to create and support groundbreaking technological collaborations is creating a dynamic medtech network with the potential for long-term societal, educational and economic impact," said Grace O'Sullivan, Vice President, ASU Corporate Engagement and Strategic Partnerships.

Share

Exclusive Research